Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A Gold-100 is a Vitamin A oral syrup manufactured by Kaiser Pharmaceuticals, an Indian pharmaceutical company. It contains Vitamin A at a concentration of 50,000 IU per 5mL and is primarily used for the treatment and prevention of Vitamin A deficiency. Vitamin A is an essential nutrient required for the maintenance of normal vision, immune system function, and cellular differentiation. Once ingested, it is metabolized into active forms such as retinal, which is crucial for the visual cycle, and retinoic acid, which acts as a ligand for nuclear receptors to regulate gene expression. The product is marketed as a branded generic and is typically supplied in a 10mL syrup formulation for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on A Gold-100.